Previously the Live Forever Club — same community, now with a sharper mission for life extension

The Lancet Infectious Diseases

Journal providing information about infectious diseases.

The Lancet Infectious Diseases was launched in August, 2001, and is a lively monthly journal of original research, review, opinion, and news covering international issues relevant to clinical infectious diseases specialists worldwide.

The Lancet Infectious Diseases has an Impact Factor of 27·516® and ranks first among infectious diseases journals (2018 Journal Citation Reports®, Clarivate Analytics 2019). The Lancet Infectious Diseases is recognised for providing a global, authoritative, and independent forum for the highest quality infectious diseases research and opinion, covering such areas as the treatment and research of HIV/AIDS, antibiotic resistance, emerging infections, and public health.

Visit website: https://www.thelancet.com/laninf/about

 TheLancetInfDis

See also

The Lancet

Medical journal covering general medicine

Details last updated 23-Nov-2019

The Lancet Infectious Diseases News

Diabetes medication metformin could lower long COVID risk by 41%, study suggests

Diabetes medication metformin could lower long COVID risk by 41%, study suggests

New Scientist - 09-Jun-2023

Metformin may function as an anti-inflammatory and potentially reduce the viral load of SARS-CoV-2

New antibiotic appears promising in early clinical trials

New antibiotic appears promising in early clinical trials

BBC - 26-Oct-2018

Superbugs are on the rise and we are running out of time

World on cusp of ‘post-antibiotic era’

World on cusp of ‘post-antibiotic era’

BBC - 19-Nov-2015

Common infections would kill once again, surgery and cancer therapies under threat. Bacteria fou...

DoNotAge supplements affiliate link